ERIS

Eris Lifesciences Limited · NSE · INE406M01024 · 272 sessions on record

₹1,189.80▼ −2.10 · −0.2%from ₹1,191.90 the session before · 1 Oct 2026 close · NSE end of day

Open: ₹1,181.30
High: ₹1,200.00
Low: ₹1,162.90
Day's range: ₹373.1% of the previous close
VWAP: ₹1,184.92close +0.41% from it
Volume, shares: 89,0000.92× the 20-session average
Turnover, ₹ crore: 11
Trades: 13,0006.8 shares per trade
Previous close: ₹1,191.90−2.10 to the close
Price band, next session: ₹1,070.80 – ₹1,308.8010% either side of the close · dynamic, widened in 5% steps when hit

Day range73% of the way up

₹1,162.90₹1,200.00

52-week range5% of the way up

₹1,162.90 1 Oct₹1,740.00 9 Dec

−32% from the high · +2.3% from the low

Futures and options

No derivatives listed on ERIS

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it

272 sessions on file · from 28 Aug

ERIS close
Nifty 50, rebased

Session read · latest close: 1 Oct 2026
Close ₹ · day %: ₹1,189.80▼ −0.2% on the previous close
Against Nifty 50: Nifty −0.9%+0.7 pp difference on the day
Against the averages: below 20 · below 5020-session ₹1,288.69 (−7.7%) · 50-session ₹1,329.04 (−10%)
Volume: 0.92×the previous 20 sessions · 89,000 shares
Extremes on the day: lowest close in 250 sessions

The market after the news

close against the last close before each bulletin · Nifty 50 over the same sessions

After the last 2 bulletins, ERIS closed higher five sessions later in 1 of 2.

Close after each bulletin on the day, one session later and five sessions later, with Nifty 50 and futures open interest
Bulletin	Day of the news	1 session later	5 sessions later	Futures OI on the day
20 MayEris Lifesciences reports strong profit growth and improved margins	▼ −5.0%Nifty 0.0% · −4.9 pp	▼ −7.8%Nifty +0.3% · −8.1 pp	▼ −4.1%Nifty −0.5% · −3.6 pp	—
5 DecEris Lifesciences to acquire 30% of Swiss Parenterals	▼ −1.1%Nifty −0.9% · −0.3 pp	▲ +9.6%Nifty −1.3% · +11.0 pp	▲ +2.2%Nifty −0.6% · +2.9 pp	—

2 of 2 bulletins

Quarterly results

consolidated · latest filed 29 Jul, 02:47 pm IST · NSE filings

Revenue ₹873 cr; profit ₹143 cr in the Jun 2026 quarter, consolidated.

Last 2 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session

Quarterly results of ERIS on the consolidated basis with the market's move on the first session after each filing
Quarter	Revenue ₹ cr	Revenue YoY	Profit ₹ cr	Profit YoY	EPS ₹	Market on the day
Jun 2026filed 29 Jul	₹873 cr	—	₹143 cr	—	10.26	▲ +2.6%Nifty +1.1% · +1.5 pp
Mar 2026filed 20 May · audited	₹757 cr	—	₹279 cr	—	20.57	▼ −5.0%Nifty 0.0% · −4.9 pp

Fundamentals

consolidated · filings to Jun 2026 · close ₹1,189.80 on 1 Oct

4.2 times book value, a 0.61% dividend yield, market cap ₹16,000 cr.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing

Market cap: ₹16,000 cron 1 Oct · free float ₹7,600 cr
Price to earnings: —fewer than four consecutive quarters filed
Trailing EPS: —fewer than four consecutive quarters filed
Price to book: 4.2consolidated · balance sheet to Mar 2026
Book value a share: ₹281.11consolidated · balance sheet to Mar 2026 · over NSE's share count
Debt to equity: 0.59borrowings over equity · consolidated · balance sheet to Mar 2026
Return on equity: —needs two filed balance sheets
Dividend yield: 0.61%₹7.21 a share in 365 days
Face value: ₹1a share
Shares outstanding: 14 cron 1 Oct

Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated

Revenue, trailing 12 months: —fewer than four consecutive quarters filed
Revenue growth, 12 months: —needs eight consecutive quarters filed
Revenue 3-year CAGR: —needs twelve consecutive quarters filed
Profit, trailing 12 months: —fewer than four consecutive quarters filed
Profit growth, 12 months: —needs eight consecutive quarters filed
Profit 3-year CAGR: —needs twelve consecutive quarters filed

PeersBSE sub-group Pharmaceuticals · F&O stocks with filings on record · industry P/E 38, market caps over trailing profit of 13 stocks

Stocks in the BSE sub-group Pharmaceuticals with market cap, price to earnings and price to book
Stock	Market cap ₹	P/E	P/B	Close ₹
SUNPHARMASun Pharmaceutical Industries Limited	4,30,000 cron 1 Oct	36consolidated	5.2	₹1,801.00
DIVISLABDivi's Laboratories Limited	2,50,000 cron 1 Oct	52consolidated	15	₹9,249.00
TORNTPHARMTorrent Pharmaceuticals Limited	1,80,000 cron 1 Oct	76consolidated	10	₹4,767.30
ZYDUSLIFEZydus Lifesciences Limited	1,10,000 cron 1 Oct	26consolidated	3.9	₹1,145.70
CIPLACipla Limited	1,10,000 cron 1 Oct	32consolidated	3.1	₹1,344.00
LAURUSLABSLaurus Labs Limited	1,10,000 cron 1 Oct	85consolidated	20	₹1,984.00
MANKINDMankind Pharma Limited	1,00,000 cron 1 Oct	51consolidated	6.3	₹2,535.00
DRREDDYDr. Reddy's Laboratories Limited	1,00,000 cron 1 Oct	31consolidated	2.6	₹1,206.20
AUROPHARMAAurobindo Pharma Limited	96,000 cron 1 Oct	26consolidated	2.5	₹1,676.80
LUPINLupin Limited	93,000 cron 1 Oct	17consolidated	4.1	₹2,031.20
GLENMARKGlenmark Pharmaceuticals Limited	66,000 cron 1 Oct	37consolidated	6.3	₹2,331.00
ALKEMAlkem Laboratories Limited	62,000 cron 1 Oct	29consolidated	4.3	₹5,220.00
BIOCONBiocon Limited	60,000 cron 1 Oct	110consolidated	1.6	₹370.70
ABBOTINDIAAbbott India Limited	57,000 cron 1 Oct	—	—	₹26,840.00
IPCALABIPCA Laboratories Limited	49,000 cron 1 Oct	—	5.2	₹1,943.20
GLANDGland Pharma Limited	47,000 cron 1 Oct	—	4.6	₹2,874.40
GLAXOGlaxoSmithKline Pharmaceuticals Limited	47,000 cron 1 Oct	—	21	₹2,771.10
AJANTPHARMAjanta Pharma Limited	45,000 cron 1 Oct	—	9.9	₹3,581.00
EMCUREEmcure Pharmaceuticals Limited	37,000 cron 1 Oct	—	7.4	₹1,944.60
WOCKPHARMAWockhardt Limited	34,000 cron 1 Oct	—	6.4	₹2,083.90
SAILIFESai Life Sciences Limited	33,000 cron 1 Oct	—	13	₹1,541.20
NEULANDLABNeuland Laboratories Limited	28,000 cron 1 Oct	—	15	₹21,505.00
RUBICONRubicon Research Limited	27,000 cron 1 Oct	—	21	₹1,630.90
PPLPHARMAPiramal Pharma Limited	26,000 cron 1 Oct	—	3.2	₹197.95
ACUTAASAcutaas Chemicals Limited	26,000 cron 1 Oct	—	15	₹3,196.50
SHILPAMEDShilpa Medicare Limited	21,000 cron 1 Oct	—	8.0	₹1,064.10
GRANULESGranules India Limited	20,000 cron 1 Oct	—	4.0	₹821.75
CAPLIPOINTCaplin Point Laboratories Limited	20,000 cron 1 Oct	—	5.5	₹2,631.90
PFIZERPfizer Limited	18,000 cron 1 Oct	—	4.2	₹3,858.90
ONESOURCEOnesource Specialty Pharma Limited	17,000 cron 1 Oct	—	3.0	₹1,508.00
COHANCECohance Lifesciences Limited	17,000 cron 1 Oct	—	4.3	₹451.30
ALIVUSAlivus Life Sciences Limited	17,000 cron 1 Oct	—	5.1	₹1,374.20
ERISEris Lifesciences Limited	16,000 cron 1 Oct	—	4.2	₹1,189.80
NATCOPHARMNatco Pharma Limited	16,000 cron 1 Oct	—	1.8	₹821.30
APLLTDAlembic Pharmaceuticals Limited	16,000 cron 1 Oct	—	2.8	₹815.25
JUBLPHARMAJubilant Pharmova Limited	16,000 cron 1 Oct	—	2.2	₹999.30
ASTRAZENAstraZeneca Pharma India Limited	15,000 cron 1 Oct	—	17	₹6,031.00
MARKSANSMarksans Pharma Limited	15,000 cron 1 Oct	—	4.8	₹325.60
CONCORDBIOConcord Biotech Limited	14,000 cron 1 Oct	—	7.1	₹1,374.10
AKUMSAkums Drugs and Pharmaceuticals Limited	13,000 cron 1 Oct	—	3.8	₹813.10
CORONACORONA Remedies Limited	12,000 cron 1 Oct	—	17	₹2,029.40
BLUEJETBlue Jet Healthcare Limited	10,000 cron 1 Oct	—	7.5	₹541.80
VIYASHViyash Scientific Limited	10,000 cron 1 Oct	—	3.3	₹231.75
STARStrides Pharma Science Limited	10,000 cron 1 Oct	—	3.2	₹1,084.80
PGHLProcter & Gamble Health Limited	8,900 cron 1 Oct	—	17	₹5,360.00
AARTIPHARMAarti Pharmalabs Limited	8,800 cron 1 Oct	—	4.1	₹968.50
SANOFICONRSanofi Consumer Healthcare India Limited	8,700 cron 1 Oct	—	25	₹3,787.20
SYMBIOTECSymbiotec Pharmalab Limited	7,700 cron 1 Oct	—	—	₹1,198.00
SUPRIYASupriya Lifescience Limited	7,500 cron 1 Oct	—	6.3	₹931.00
MOREPENLABMorepen Laboratories Limited	7,300 cron 1 Oct	—	5.9	₹133.70
SANOFISanofi India Limited	7,000 cron 1 Oct	—	8.5	₹3,037.40
INNOVACAPInnova Captab Limited	6,700 cron 1 Oct	—	6.1	₹1,168.00
SPARCSun Pharma Advanced Research Company Limited	6,300 cron 1 Oct	—	4.7	₹194.15
SENORESSenores Pharmaceuticals Limited	6,200 cron 1 Oct	—	6.4	₹1,349.60
IOLCPIOL Chemicals and Pharmaceuticals Limited	6,100 cron 1 Oct	—	3.4	₹209.40
ORCHPHARMAOrchid Pharma Limited	5,900 cron 1 Oct	—	4.6	₹990.00
FDCFDC Limited	5,500 cron 1 Oct	—	2.2	₹335.90
GUJTHEMGujarat Themis Biosyn Limited	5,000 cron 1 Oct	—	—	₹381.80
NOVARTINDNovartis India Limited	4,900 cron 1 Oct	—	—	₹1,965.00
RPGLIFERPG Life Sciences Limited	4,800 cron 1 Oct	—	8.0	₹2,930.70
SMSPHARMASMS Pharmaceuticals Limited	4,400 cron 1 Oct	—	5.6	₹471.30
GUFICBIOGufic Biosciences Limited	4,200 cron 1 Oct	—	6.3	₹418.40
AARTIDRUGSAarti Drugs Limited	3,800 cron 1 Oct	—	2.5	₹421.00
UNICHEMLABUnichem Laboratories Limited	3,800 cron 1 Oct	—	1.4	₹535.05
KPLKwality Pharmaceuticals Limited	3,700 cron 1 Oct	—	—	₹3,564.40
SOLARASolara Active Pharma Sciences Limited	3,400 cron 1 Oct	—	2.7	₹714.85
INDSWFTLABInd-Swift Laboratories Limited	3,400 cron 1 Oct	—	2.5	₹395.15
SHUKRAPHARShukra Pharmaceuticals Limited	2,700 cron 1 Oct	—	—	₹61.80
HIKALHikal Limited	2,700 cron 1 Oct	—	2.2	₹218.15
VENUSREMVenus Remedies Limited	2,400 cron 1 Oct	—	3.6	₹1,796.70
DCALDishman Carbogen Amcis Limited	2,400 cron 1 Oct	—	0.35	₹150.35
INDOCOIndoco Remedies Limited	2,300 cron 1 Oct	—	2.5	₹251.75
SAIPARENTSai Parenterals Limited	2,300 cron 1 Oct	—	4.7	₹523.65
SYNCOMFSyncom Formulations (India) Limited	2,300 cron 1 Oct	—	5.4	₹23.95
FREDUNFredun Pharmaceuticals Limited	2,200 cron 1 Oct	—	—	₹1,355.20
WINDLASWindlas Biotech Limited	2,200 cron 1 Oct	—	—	₹1,082.40
PANACEABIOPanacea Biotec Limited	2,200 cron 1 Oct	—	2.6	₹359.05
HESTERBIOHester Biosciences Limited	1,800 cron 1 Oct	—	4.9	₹2,126.80
NGLFINENGL Fine-Chem Limited	1,800 cron 1 Oct	—	5.5	₹2,924.00
AHCLAnlon Healthcare Limited	1,700 cron 1 Oct	—	6.8	₹32.85
FERMENTAFermenta Biotech Limited	1,600 cron 1 Oct	—	—	₹553.25
JAGSNPHARMJagsonpal Pharmaceuticals Limited	1,500 cron 1 Oct	—	5.5	₹231.75
AMRUTANJANAmrutanjan Health Care Limited	1,500 cron 1 Oct	—	4.0	₹513.20
KOPRANKopran Limited	1,400 cron 1 Oct	—	2.6	₹282.05
BPLPHARMABharat Parenterals Limited	1,200 cron 1 Oct	—	—	₹1,720.40
LINCOLNLincoln Pharmaceuticals Limited	1,200 cron 1 Oct	—	1.5	₹582.05
BAJAJHCAREBajaj Healthcare Limited	1,100 cron 1 Oct	—	2.0	₹322.95
SIGACHISigachi Industries Limited	1,100 cron 1 Oct	—	2.0	₹28.35
THEMISMEDThemis Medicare Limited	1,000 cron 1 Oct	—	2.6	₹113.20
SGRLShree Ganesh Remedies Limited	890 cron 1 Oct	—	—	₹694.25
ANUHPHRAnuh Pharma Limited	860 cron 1 Oct	—	2.4	₹85.85
ZIMLABZim Laboratories Limited	740 cron 1 Oct	—	2.5	₹137.00
WANBURYWanbury Limited	690 cron 1 Oct	—	4.8	₹198.00
ALBERTDAVDAlbert David Limited	490 cron 1 Oct	—	1.3	₹856.70
MEDICAMEQMedicamen Biotech Limited	470 cron 17 Sept	—	1.7	₹346.30
HALEOSLABSHALEOS LABS LIMITED	450 cron 1 Oct	—	2.0	₹1,490.00
JENBURPHJenburkt Pharmaceuticals Limited	400 cron 1 Oct	—	—	₹915.25
AAREYDRUGSAarey Drugs & Pharmaceuticals Limited	290 cron 1 Oct	—	2.0	₹103.85
NECLIFENectar Lifesciences Limited	200 cron 1 Oct	—	0.34	₹10.25
MEDICOMedico Remedies Limited	180 cron 1 Oct	—	2.4	₹21.85
BALPHARMABal Pharma Limited	170 cron 1 Oct	—	2.0	₹105.75
BROOKSBrooks Laboratories Limited	160 cron 1 Oct	—	1.3	₹54.80
KREBSBIOKrebs Biochemicals and Industries Limited	150 cron 1 Oct	—	—	₹68.05
PARNAXLABParnax Lab Limited	130 cron 1 Oct	—	—	₹113.15
ALPAAlpa Laboratories Limited	120 cron 1 Oct	—	0.67	₹59.25
MAKERSLMakers Laboratories Limited	110 cron 1 Oct	—	—	₹183.50
SUNLOCSunil Healthcare Limited	72 cron 1 Oct	—	—	₹70.10
VINEETLABVineet Laboratories Limited	69 cron 1 Oct	—	1.5	₹35.90
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited	48 cron 1 Oct	—	2.2	₹29.30
MANGALAMMangalam Drugs And Organics Limited	46 cron 1 Oct	—	0.45	₹29.15
MEDICAPQMedi Caps Limited	31 cron 17 Sept	—	—	₹24.80
ORTINGLOBEORTIN GLOBAL LIMITED	12 cron 1 Oct	—	9.5	₹14.50
AMANTAAmanta Healthcare Limited	—	—	—	—
AMBALALSAAmbalal Sarabhai Enterprises Limited	—	—	—	—
BAFNAPHBafna Pharmaceuticals Limited	—	—	—	—
BLISSGVSBliss GVS Pharma Limited	—	—	—	—
KILITCHKilitch Drugs (India) Limited	—	—	—	—
LASALasa Supergenerics Limited	—	—	—	—
LYKALABSLyka Labs Limited	—	—	—	—
NATCAPSUQNatural Capsules Limited	—	—	—	—
VALIANTLABValiant Laboratories Limited	—	—	—	—
VIVIMEDLABVivimed Labs Limited	—	—	—	—

Shareholding

quarter to 30 Jun · 17% of the promoter holding pledged · NSE filings

Promoters hold 54.1%, foreign portfolio investors 5.8%, mutual funds 18.9% and insurance companies 1.1%, as filed for the quarter to 30 Jun.

54.1%18.9%10.3%9.1%

By category, last 2 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file

Shareholding of ERIS by category over the last 2 quarters with the change against the previous quarter
Category	30 Jun	31 Mar
Promoters	54.14▲ +0.22 pp	53.92
Foreign portfolio investors	5.76▼ −0.63 pp	6.39
Mutual funds	18.88▲ +0.66 pp	18.22
Insurance companies	1.13▼ −0.18 pp	1.31
Banks and financial institutions	0.70▼ −0.12 pp	0.82
Individual investors	10.26▲ +0.04 pp	10.22
Bodies corporate	0.29▲ +0.02 pp	0.27
Other foreign holders	8.63▼ −0.01 pp	8.64
Others	0.210.00 pp	0.21

Corporate actions

NSE and BSE records

Nothing upcoming on record; the last was a dividend of ₹7.21 a share, ex-date 29 May 2026.

Actionsex-dates · upcoming first, then the last eight · dividends in rupees a share, bonus and split as ratios

Corporate actions of ERIS, upcoming first, then the most recent
Ex-date	Action	Amount or ratio	Record date	Source
recent
29 May 2026	dividend	₹7.21	29 May 2026	NSE
13 Feb 2025	dividend	₹7.35	13 Feb 2025	NSE
17 Sept 2024	otherAnnual General Meeting	—	—	NSE

Calendaras notified to the exchange

Next results: —no board meeting notified yet
Dividends in 365 days: ₹7.21a share · ex-dates inside the year
Last dividend: ₹7.21ex-date 29 May 2026

Price history

272 sessions on record · to 1 Oct · NSE end of day

ERIS is −7.7% over 20 sessions against Nifty's −6.2%, 32% below its 52-week high, realised volatility 22% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions

Returns of the stock and Nifty 50 over six windows, longest first
Window	From ₹	ERIS %	Nifty 50 %	Difference pp
250 sessionssince 26 Sept	₹1,585.55	▼ −25%	▼ −9.1%	−16
120 sessionssince 9 Apr	₹1,364.14	▼ −13%	▼ −5.7%	−7.1
60 sessionssince 8 Jul	₹1,415.92	▼ −16%	▼ −6.1%	−9.9
20 sessionssince 2 Sept	₹1,288.92	▼ −7.7%	▼ −6.2%	−1.5
5 sessionssince 24 Sept	₹1,274.56	▼ −6.6%	▼ −2.8%	−3.9
1 sessionsince 30 Sept	₹1,191.95	▼ −0.18%	▼ −0.88%	+0.70

Averages of the closeclose against each average

5-session average: ₹1,219.24close −2.4% from it
20-session average: ₹1,288.69close −7.7% from it
50-session average: ₹1,329.04close −10% from it
200-session average: ₹1,388.64close −14% from it

Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average

Average true range, 14: ₹443.7% of the close
Average day's range, 20: ₹373.1% of the close
Volume against 20 sessions: 0.92×89,000 vs 93,000 average

Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell

Realised volatility, 20: 22%≈ ±1.4% a session · moved more than that on 8 of 20
Realised volatility, 60: 22%≈ ±1.4% a session · moved more than that on 20 of 60
Realised volatility, 250: 30%≈ ±1.9% a session · moved more than that on 61 of 250
Beta to Nifty, 60: 0.54moved with Nifty on 36 of 60 sessions
Beta to Nifty, 250: 0.57moved with Nifty on 142 of 250 sessions

Up and down sessionscloses above and below the previous close

Last 20 sessions: 9 up · 11 downof 20
Last 60 sessions: 31 up · 29 downof 60
Last 250 sessions: 117 up · 133 downof 250
Best session, 250: ▲ +11%9 Dec
Worst session, 250: ▼ −6.4%13 Feb

Eris Lifesciences Limited is in 10 NSE indices

all 10 indices

2 bulletins on ERIS

latest 20 May 2026

Beats in the coverage

Pharma2

May 2026

20 May Eris Lifesciences reports strong profit growth and improved marginsEris Lifesciences reported strong revenue and profit growth, driven by improved margins and strategic acquisitions. The company declared an interim dividend, benefiting from favorable tax changes, which may enhance investor sentiment.High

December 2025

5 Dec Eris Lifesciences to acquire 30% of Swiss ParenteralsHigh

About Eris Lifesciences Limited

exchange masters as of 18 Sept 2026 · classification by BSE

Company: Eris Lifesciences Limited
Exchange: NSE · BSE 540596, group A
Listed on NSE: 29 Jun 2017
Classification: Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
Index: BSE 500
Face value: ₹1 a share
ISIN: INE406M01024
Sessions on record: 272
Price source: NSE UDiFF bhavcopy · end of day · delayed
Filings: NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed: 2 Oct, 02:27 am IST
Bulletins: 2 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.